Company: BKYI
Filing Date: 2025-12-02
Form Type: 424B3
Source: 0001437749-25-036669
Chunk: 7

Company: BIO KEY INTERNATIONAL INC
Filing Date: 2025-12-02
Form: 424B3
Chunk 7
---
 of shares of our common stock to be outstanding after this offering is based on 10,836,618 shares of our common stock outstanding as of November 13, 2025, plus an aggregate of 6,183,336 shares of common stock issuable upon exercise of the Warrants, and excludes as of such date:

| ● | 1,857 shares of common stock issuable upon the exercise of stock options, with a weighted-average exercise price of $144.71 per share;        |
| ● | 11,112 shares of common stock issuable upon the exercise of outstanding warrants, with a weighted-average exercise price of $54,00 per share; |
| ● | 421,905 shares of common stock issuable on exercise of warrants with an exercise price of $3.15 per share;                                    |
| ● | 31,131 shares of common stock issuable upon exercise of pre-funded warrants with an exercise price of $0.0018 per share;                      |
| ● | 732,548 shares of common stock reserved for future issuance under our Amended 2021 Employee Stock Purchase Plan;                              |
| ● | 575,569 shares of common stock reserved for future issuance under our Amended 2023 Stock Incentive Plan.                                      |

<div align='center'>RISK FACTORS</div>

Investing in our securities involves a high degree of risk. Before deciding to invest in our securities, you should consider carefully the risks and uncertainties described below and under Item 1A.“Risk Factors”in our Annual Report on Form 10-K for the year ended December 31, 2024, filed with the Securities and Exchange Commission, or SEC, on April 23, 2025, which are incorporated by reference in this prospectus, together with all of the other information contained in this prospectus and documents incorporated by reference herein, and in any free writing prospectus that we have authorized for use in connection with this offering. If any of the matters discussed in the following risk factors were to occur, our business, financial condition, results of operations, cash flows or prospects could be materially adversely affected, the market price of our common stock could decline and you could lose all or part of your investment in our securities. Additional risks and uncertainties not presently known or which we consider immaterial as of the date hereof may also have an adverse effect on our business.

<div align='center'>RISKS RELATED TO THIS OFFERING</div>

Sales of a substantial number of